Intra-Cellular Therapies

We are pleased to share that today we announced an agreement to become?a part of Johnson & Johnson, a company with?a longstanding commitment to neuroscience. We believe together, we can impact many more patients worldwide.?Please refer to today’s full announcement for key information and cautionary statements: https://lnkd.in/eMy37TRz

Intra-Cellular Therapies is looking forward to the Medscape Psychiatry Update meeting, taking place March 20-22 in Chicago! ? We will be holding a Non-CME/CE Bonus Presentation Friday, March 21, at 3:05 PM on The Evolution of Specifiers and a Treatment Option for both Bipolar I and Bipolar II Depression in Adults, presented by Joseph F. Goldberg, MD. To view the program virtually, click here to register: https://lnkd.in/eDRaBgjy ? If you are attending in person, make sure to also stop by our exhibit booth. We look forward to seeing you there!?

Happy Scientists Day! Today, we honor the bright minds at Intra-Cellular Therapies who are at the forefront of innovation and research, whose pursuit of knowledge drives our progress in discovering innovative treatments. Thank you for your dedication, hard work and discoveries that are improving lives! ? #ScientistsDay?

On this International Women's Day, we celebrate the incredible women at Intra-Cellular Therapies who drive our mission forward every day, with their talent, passion, and dedication. From our innovative researchers and visionary leaders to our dedicated team members across every department, your contributions are vital to helping those with complex neuropsychiatric conditions. Thank you for pushing boundaries, breaking barriers, and inspiring us all to reach new heights. Here's to the women who lead, inspire, and empower—today and every day! ?#IWD2025 #WomenInSTEM?

On Employee Appreciation Day, we’re celebrating the dedication, passion, and hard work of every ITCI employee. Thank you to our incredible team! ? #ITCI #EmployeeAppreciationDay

AMSUS, The Society of Federal Health Professionals, is holding their Annual Meeting March 3 -6 in National Harbor, Maryland. If you are attending in person, make sure to visit us at booth #617!?We will also be hosting a Product Theater Presentation on Caring for Service Member and Veteran Populations: A Deeper Look at Bipolar Disorder on Wednesday, March 5th, at 12:15 PM. We look forward to seeing you there!

Intra-Cellular Therapies proudly sponsors “The?Brainery,” an interactive, on-demand learning platform centered around bipolar disorder. A new course, “Making a Difference in the Differential Diagnosis of Bipolar Disorder” is available. In this course, healthcare professionals will be guided through differentiating between some of the more common mood disorders. The topics are broken up into short lessons that are focused on differentiating between bipolar disorder and major depressive disorder, differential diagnosis of comorbid disorders including borderline personality disorder, ADHD, substance use disorders, schizophrenia and anxiety disorders. Take a look. https://lnkd.in/eEffmQAm

February 12-15 is the 30th Annual National Psychopharmacology Update, hosted by the Nevada Psychiatric Association. If you are attending in person, make sure to visit us at Booth 408!

Today is the International Day of Women and Girls in Science and we want to highlight the incredible women at Intra-Cellular Therapies (ITCI) who are making significant contributions to our research and drug development efforts. Their dedication, passion, and unwavering commitment to advancing science and improving lives are truly inspiring. ? Join us in celebrating these extraordinary women and their contributions to science. #WomenInScience #STEM #IntraCellularTherapies #ITCI

Congratulations to ITCI CEO Dr. Sharon Mates on being named one of the Top 50 Women Leaders in Healthcare Technology! This recognition is a testament to her visionary leadership and her unwavering dedication to help patients.? #HealthcareTechnology #MentalHealthMatters??